相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cathepsin K inhibitors: A novel target for osteoporosis therapy
S. A. Stoch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Zoledronic acid inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancer
Adam Brufsky et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: A report from the Austrian Breast and Colorectal Cancer Study Group
Michael F. X. Gnant et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Prevention of bone loss in survivors of breast cancer: A randomized, double-blind, placebo-controlled clinical trial
Susan L. Greenspan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Denosumab in postmenopausal women with low bone mineral density
MR McClung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate
NB Watts et al.
JOURNAL OF CLINICAL DENSITOMETRY (2004)
Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer
CL Shapiro et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Risedronate -: A clinical review
C Crandall
ARCHIVES OF INTERNAL MEDICINE (2001)